Changing Trial Logistics and How They Effect Development

The movement of clinical supplies to investigator sites is becoming more complex and costly. However, a supply shortfall can prevent continuation of an on-going trial, imperilling the programme, and preventing study patients from receiving drugs a sponsor has committed to provide. Supply chain logistics are estimated to account for as much as 25% of the total annual pharmaceutical research and development (R&D) costs, the pressures of which are expected to grow as a result of an evolution that is altering the clinical trial landscape and generating complex supply chain logistic challenges. Download this free whitepaper to find out more about challenges and escalating logistical costs, as well as six developments in supply change logistics (falling temperatures, increasingly global studies, short supply, driving demand for 24/7 tracking of supply shipments, patient centricity, and flexibility and contingency planning.